Literature DB >> 8467429

Detection of Lewy bodies in Trisomy 21 (Down's syndrome).

R Raghavan1, C Khin-Nu, A Brown, D Irving, P G Ince, K Day, S P Tyrer, R H Perry.   

Abstract

The presence of cortical senile plaques and neurofibrillary tangles sufficient to warrant a neuropathological diagnosis of Alzheimer's disease is well established in middle-aged individuals with Trisomy 21 (Down's syndrome). In contrast a relationship between Down's syndrome and Lewy bodies, one of the major neuropathological features of Parkinson's disease, has not been previously reported. In a clinico-neuropathological survey of 23 cases of Down's Syndrome, two patients, aged 50 and 56 years respectively, were found to have Lewy body formation in the substantia nigra in addition to cortical Alzheimer-type pathology. Neither case showed significant substantia nigra neuron loss although locus coeruleus loss was present in both. Since substantia nigra Lewy bodies are a characteristic neurohistological feature of idiopathic Parkinson's disease, their occurrence in cases of Down's syndrome with evidence of Alzheimer-type pathology supports an aetiopathological connection between Parkinson's disease, Alzheimer's disease, and Down's syndrome; and suggests that common pathogenic mechanisms may underlie aspects of neuronal degeneration in these three disorders, some of which may relate to aberrant chromosome 21 expression.

Entities:  

Mesh:

Year:  1993        PMID: 8467429     DOI: 10.1017/s0317167100047405

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  13 in total

1.  Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.

Authors:  Lani K Clinton; Mathew Blurton-Jones; Kristoffer Myczek; John Q Trojanowski; Frank M LaFerla
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.

Authors:  Gonçalo M Poças; Joana Branco-Santos; Federico Herrera; Tiago Fleming Outeiro; Pedro M Domingos
Journal:  Hum Mol Genet       Date:  2014-12-01       Impact factor: 6.150

3.  Down's syndrome and Parkinson's disease.

Authors:  A Hestnes; S E Daniel; A J Lees; A Brun
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

4.  Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.

Authors:  Satoshi Yamashita; Naomi Sakashita; Taro Yamashita; Nozomu Tawara; Masayoshi Tasaki; Kensuke Kawakami; Yoshihiro Komohara; Yukio Fujiwara; Masashi Kamikawa; Takenobu Nakagawa; Teruyuki Hirano; Yasushi Maeda; Masato Hasegawa; Motohiro Takeya; Yukio Ando
Journal:  J Neurol       Date:  2014-09-11       Impact factor: 4.849

5.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Authors:  C F Lippa; H Fujiwara; D M Mann; B Giasson; M Baba; M L Schmidt; L E Nee; B O'Connell; D A Pollen; P St George-Hyslop; B Ghetti; D Nochlin; T D Bird; N J Cairns; V M Lee; T Iwatsubo; J Q Trojanowski
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

Review 6.  Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.

Authors:  Kelly M Bakulski; Young Ah Seo; Ruby C Hickman; Daniel Brandt; Harita S Vadari; Howard Hu; Sung Kyun Park
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

7.  Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.

Authors:  Nahuai Badiola; Rita Machado de Oliveira; Federico Herrera; Cristina Guardia-Laguarta; Susana A Gonçalves; Marta Pera; Marc Suárez-Calvet; Jordi Clarimon; Tiago Fleming Outeiro; Alberto Lleó
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 8.  Examining the mechanisms that link β-amyloid and α-synuclein pathologies.

Authors:  Samuel E Marsh; Mathew Blurton-Jones
Journal:  Alzheimers Res Ther       Date:  2012-04-30       Impact factor: 6.982

9.  Levodopa-Responsive Early-Onset Parkinsonism in Down Syndrome.

Authors:  Padmini Palat; Francis Hickey; Lina Patel; Elise Sannar
Journal:  Case Rep Neurol Med       Date:  2018-02-15

10.  α-Synuclein Oligomers Induce a Unique Toxic Tau Strain.

Authors:  Diana L Castillo-Carranza; Marcos J Guerrero-Muñoz; Urmi Sengupta; Julia E Gerson; Rakez Kayed
Journal:  Biol Psychiatry       Date:  2018-01-17       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.